Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling.

Psychopharmacology
A F Arnsten

Abstract

Bipolar disorder and schizophrenia are associated with profound dysfunction of the prefrontal cortex (PFC), with bipolar disorder most associated with changes in ventromedial PFC and schizophrenia more associated with changes in dorsolateral PFC. Recent genetic and biochemical studies have also linked these illnesses to disinhibition of phosphotidyl inositol-protein kinase C signaling. For example, DAG kinase eta, an enzyme that metabolizes DAG and thus reduces protein kinase C activity, is the gene most altered in bipolar disorder. Similarly, regulator of G protein signaling 4 is the molecule most altered in the PFC of patients with schizophrenia, and this molecule normally serves to inhibit Gq signaling. Animal studies have shown that high levels of phosphotidyl inositol-protein kinase C signaling in the PFC markedly impair PFC function at the behavioral and cellular levels. Most importantly, many effective medications for bipolar disorder and schizophrenia inhibit phosphotidyl inositol-protein kinase C signaling, either through intracellular actions (lithium, valproate) or through extracellular blockade of receptors coupled to this pathway (5HT2 receptors and alpha-1 adrenoceptors). Recent data suggest that lithium and valpr...Continue Reading

References

Dec 1, 1992·Current Opinion in Neurobiology·P S Goldman-RakicM V Chafee
Jun 1, 1992·Journal of Consulting and Clinical Psychology·D T StussC R Hetherington
Oct 6, 1989·JAMA : the Journal of the American Medical Association·M J Berridge
Jan 1, 1987·Neuropsychologia·A J WilkinsR McCarthy
May 1, 1970·Experimental Neurology·P S Goldman, H E Rosvold
Jul 1, 1983·Physiological Reviews·S L FooteG Aston-Jones
Mar 1, 1995·Neuron·P S Goldman-Rakic
Jan 1, 1995·The American Journal of Psychiatry·R YehudaL J Siever
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·B L MurphyR H Roth
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F P BymasterD T Wong
Oct 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·P S Goldman-Rakic
Oct 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·T W Robbins
Oct 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D R Weinberger, K F Berman
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·J R HeplerT Kozasa
Apr 1, 1997·Current Opinion in Cell Biology·A C Newton
Oct 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·P L MorrisM J Hopwood
Jun 1, 1997·The American Journal of Psychiatry·C Hammen, M Gitlin
Nov 5, 1997·Advances in Pharmacology·W Schultz
Jul 11, 1998·Science·A F Arnsten
Jan 23, 1999·Biological Psychiatry·L D Selemon, P S Goldman-Rakic
Apr 17, 1999·The Journal of Biological Chemistry·M K Topham, S M Prescott
Oct 12, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B M LiZ T Mei
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·M LepageE Tulving
Jan 13, 2000·Archives of General Psychiatry·L A Glantz, D A Lewis
Jan 13, 2000·Archives of General Psychiatry·J M BebchukH K Manji
Aug 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R A AveryA F Arnsten
Aug 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B E SwartzM A Mandelkern
Nov 10, 2000·Lancet·G J MooreH K Menji
Dec 6, 2000·Progress in Brain Research·G Aston-JonesJ Cohen

❮ Previous
Next ❯

Citations

Mar 19, 2013·Behavioural Brain Research·Amber LockridgeLi-Lian Yuan
Oct 21, 2011·Dose-response : a Publication of International Hormesis Society·Robert G MairJacqueline R Hembrook
Aug 2, 2011·Chemical Reviews·Yulia V ShulgaRichard M Epand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.